Patents - Global Data - Dimensions
Grant
Liquid formulations of daptomycin
Applicants
- Xellia (Denmark)
[NORA names: Xellia; Private Research]
Abstract
The present invention relates to liquid pharmaceutical compositions comprising daptomycin, methods of providing such compositions, and the use thereof. Provided herein are formulations comprising daptomycin, one or more polar protic solvents, and mixtures thereof. Formulations according to the present invention may further comprise a polar aprotic solvent and/or a source of calcium. (Automatic translation with Google Translate, without legal value)
Patent Family Records (6)
liquid formulations of daptomycin
Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA
2023, ES-2946600-T3
LIQUID FORMULATIONS OF DAPTOMYCIN
Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA
2023, EP-3528786-B1
Liquid formulations of daptomycin
Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA
2021, US-10933019-B2
LIQUID FORMULATIONS OF DAPTOMYCIN
Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA
2019, US-20190240155-A1
LIQUID FORMULATIONS OF DAPTOMYCIN
Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA
2019, EP-3528786-A1
LIQUID FORMULATIONS OF DAPTOMYCIN
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) GJONI TINA, STRAZIC DUBRAVKA
2018, WO-2018073269-A1